Phase III/Seroquel SR Bipolar Depression Monotherapy - US

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Depression for 8 weeks.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Affective Psychosis, Bipolar Bipolar Disorder Bipolar and Related Disorders Depression, Bipolar Manic-Depressive Psychosis Mental Disorders Mood Disorders Psychoses, Manic-Depressive

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Research Site, Birmingham, Alabama, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Provision of written informed consent
Documented diagnosis of Bipolar 1 disorder or Bipolar 11 disorder
Outpatient status at enrollment

Exclusion criteria

Patients with >8 mood episodes during the past 12 years
Use of prohibited medications
Substance or alcohol abuse or dependence
Current suicide risk or suicide attempt within last 6 months.

Treatment and study plan

Quetiapine fumarate (Seroquel) SR

Drug

Primary outcomes

Change from baseline in depression symptoms by final visit as measured by the MADRS total score

Secondary outcomes

Change from baseline to final visit on the MADRS total score MADRS item scores, CGI-BP-S, CGI-BP-C

Sponsors and collaborators

Lead sponsor

AstraZeneca

Industry

Registry information

Official study title

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (Seroquel SR®) Sustained-Release as Monotherapy in Adult Patients With Acute Bipolar Depression

Important dates

Study start: 2006
Study completion: 2007
First posted: Jan 15, 2007
Registry last updated: Mar 25, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed